Robert Cusick, MD
Adult Reconstructive Orthopaedic Surgery · Champaign, ILNPI 1184606790
Payments from drug & device makers
What this record shows
This record is dominated by ownership interests: $22,000 of the $27,629 with a category attached, or 79.6%. Midwest Surgical Alliance, LLC accounts for 79.6% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $22,437 and has fallen 90.9% since, to $2,035 in 2025.
Across 88 payments — averaging $313.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Midwest Surgical Alliance, LLC$22K
- Stryker$4K
- Encore Medical, LP$913
- Johnson & Johnson$154
- Pacira Therapeutics, Inc.$79
- Ferring Pharmaceuticals Inc.$54
- plus $185 from 7 others
What the payments were for
- Travel & lodging$2,76110%
- Food & beverage$2,86810%
- Ownership interest$22,00080%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Midwest Surgical Alliance, LLC | 1 | $22,000 |
| Stryker | 61 | $4,244 |
| Encore Medical, LP | 4 | $913 |
| Johnson & Johnson(2 entities) | 6 | $154 |
| Pacira Therapeutics, Inc. | 4 | $79 |
| Ferring Pharmaceuticals Inc. | 3 | $54 |
| Orthofix Medical, Inc. | 2 | $48 |
| Sanofi-aventis U.S. LLC | 2 | $37 |
| Bioventus LLC | 1 | $28 |
| Merck | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| Amgen | 1 | $17 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$2,170
- DJO Surgical TaperFill Hip System$719
- AEQUALIS PERFORM$173
- DJO SURGICAL$149
- TRIATHLON$120
- T2$112
How this compares
$27,629 in reported general payments places this provider in the 70th percentile of 67 adult reconstructive orthopaedic surgery providers in Illinois.
See all adult reconstructive orthopaedic surgery providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $231 |
| Meloxicam | 26 | $59 |
| Amoxicillin | 42 | $38 |
| Cephalexin | 15 | $27 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Champaign
- Wayne PaproskyWinfield$10.9M
- Scott SporerWinfield$5.3M
- Denis NamChicago$3.2M
- Craig della ValleChicago$2.4M
- Hany BedairChicago$1.1M
- Linda SuleimanChicago$898K
- Tad GerlingerChicago$642K
- Henry FinnChicago$523K
- Vasili KarasChicago$264K
- Brett LevineChicago$250K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.